Zoledronic Acid for Injection
Product Description
Jiangsu Hengrui Medicine Co., Ltd.
-
CN -
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Categories
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)
-
Product Tacrolimus, Capsule, Extended Release
Tacrolimus is an immunosuppressive drug used mainly after allogeneic organ transplant to lower the risk of organrejection. It achieves this by inhibiting the production of interleukin-2, a molecule that promotes the development and proliferation of T cells,... -
Product Trabectedin for Injection
Trabectedin for Injection is an anti-tumor chemotherapy drug.
Strength: 0.25mg; 1mg
US-ANDA in preparation.Dossiers for EU market approval: in preparation.
-
Product Apatinib Mesylate Tablets
It is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor.
Strength: 0.25g; 0.375g; 0.425g
NMPA approved.
-
Product Pegaspargase Injection
It is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. It is used in the treatment of acute lymphoblastic leukemia.
Strength: 5ml:3750IU; 2ml:1500IU
It has... -
Product Tegafur, Gimeracil, Oteracil Potassium Capsules
It is used for the treatment of advanced gastric cancer.
Strength:
Tegafur: 20mg, Gimeracil: 5.8mg, Oteracil potassium: 19.6mg;
Tegafur: 25mg, Gimeracil: 7.25mg, Oteracil potassium: 24.5mg
It has been approved by NMPA.
-
Product Temozolomide for Injection
It is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
Strength: 100mg
It has been approved by CFDA.
-
Product Bupivacaine Liposome Injectable Suspension
It is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, andepidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action.
Strength: 133mg/10ml... -
Product Eribulin Mesylate Injection
Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.
Strength: 1mg/2ml
This product is still in R & D stage.
-
Product Gadobutrol Injection
Gadobutrol Injection is a gadolinium-based MRI contrast agent (GBCA).
Strength: (604.72mg/ml) *2ml *7.5ml *10ml *15ml *30ml *65ml
This product is still in R & D stage.
-
Product Gadobenate Dimeglumine injection
This is a kind of contrast media.
Strength: (529mg/ml) *5ml *10ml *15ml *20ml
It is still in R&D stage. -
Product Iohexol Injection
Iohexol is a kind of contrast media.
Strength: to be determined.
This product is still in R&D stage.
-
Product Ioversol Injection
Ioversol is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups.
Strength: 320mg I/ml (50ml; 100ml)
Dossiers are in preparation for US-FDA approval.
Jiangsu Hengrui Medicine Co., Ltd. resources (1)
-
Brochure Hengrui Medicine - Company Details
Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance